Can pharmacotherapy effectively reduce Alzheimer’s related agitation?

Madia Lozupone; Maddalena La Montagna; Rodolfo Sardone; Davide Seripa; Antonio Daniele; Francesco Panza

doi:10.1080/14656566.2020.1770730

Can pharmacotherapy effectively reduce Alzheimer’s related agitation?

Madia Lozupone
, Maddalena La Montagna
, Rodolfo Sardone
, Davide Seripa
, Antonio Daniele
, Francesco Panza

University of Bari
University of Foggia
Research Hospital
IRCCS Ospedale Casa Sollievo della Sofferenza - San Giovanni Rotondo (FG)

Risultato della ricerca: Contributo in rivista › Articolo

2 Citazioni (Scopus)

Abstract

N/A

Lingua originale	Inglese
pagine (da-a)	1517-1522
Numero di pagine	6
Rivista	Expert Opinion on Pharmacotherapy
Volume	21
DOI	https://doi.org/10.1080/14656566.2020.1770730
Stato di pubblicazione	Pubblicato - 2020

Keywords

Agitation
Alzheimer’s disease
aggression
amyloid-β
brexpiprazole
cannabinoids
citalopram
dextromethorphan/quinidine
electroconvulsive therapy
nabilone

Accesso al documento

10.1080/14656566.2020.1770730

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{d5c1c150f2ce491995d45471e9955824,

title = "Can pharmacotherapy effectively reduce Alzheimer{\textquoteright}s related agitation?",

abstract = "N/A",

keywords = "Agitation, Alzheimer{\textquoteright}s disease, aggression, amyloid-β, brexpiprazole, cannabinoids, citalopram, dextromethorphan/quinidine, electroconvulsive therapy, nabilone, Agitation, Alzheimer{\textquoteright}s disease, aggression, amyloid-β, brexpiprazole, cannabinoids, citalopram, dextromethorphan/quinidine, electroconvulsive therapy, nabilone",

author = "Madia Lozupone and \{La Montagna\}, Maddalena and Rodolfo Sardone and Davide Seripa and Antonio Daniele and Francesco Panza",

year = "2020",

doi = "10.1080/14656566.2020.1770730",

language = "English",

volume = "21",

pages = "1517--1522",

journal = "Expert Opinion on Pharmacotherapy",